Reference: Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., Chen, W., Zhang, H., Liu, Q., Zhu, R., Shi, Y., Shen, Z., Xing, Z., Gao, W., Zhou, L., Shao, J., Shi, J., Yang, X., Deng, Y., Wu, L., Lin, Q., Zheng, C., Zhu, W., Wang, C., Sun, Y. E., & Liu, Z. […]
Reference: Bruno, R., McCullough, P., et al. (2021). 157 Top Scientists and Doctors Release Shocking Study on COVID Vaccines and Demand Immediate Stop to All Vaccinations. Global Research. Summary: A report by 57 prominent scientists and doctors has raised significant concerns about the safety and efficacy of COVID-19 vaccines, urging an immediate cessation of vaccination
Reference: U.S. Food and Drug Administration. (2021, May 19). Antibody testing is not currently recommended to assess immunity after COVID-19 vaccination: FDA safety communication. https://www.fda.gov/medical-devices/safety-communications/antibody-testing-not-currently-recommended-assess-immunity-after-covid-19-vaccination. Summary: The FDA has issued a warning that antibody tests for SARS-CoV-2 should not be used to determine immunity following COVID-19 vaccination. While these tests can indicate previous infection, they
Reference: Informed Consent Action Network. (2022). V-safe data. https://icandecide.org/v-safe-data/#v-safe-downloads Summary: The V-Safe Data report from the Informed Consent Action Network (ICAN) presents comprehensive statistics on adverse health impacts following COVID-19 vaccinations. The data indicates that over 10 million individuals registered on the V-Safe platform, with significant health impacts reported, totalling approximately 6.4 million. The report
Reference: Kory, P., Meduri, G. U., Varon, J., Iglesias, J., & Marik, P. E. (2021). Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. American Journal of Therapeutics, 28(3), e299–e318. https://doi.org/10.1097/MJT.0000000000001163 Summary: This article reviews evidence supporting ivermectin as an effective treatment and prophylactic agent for COVID-19.
Reference: General patient consent form for pharmacies during 2021. Summary: General consent form drawn up for pharmacies dispensing Ivermecting to patients during 2021. DOWNLOAD
Reference: Law, B. (2020). Priority List of COVID-19 Adverse events of special interest: Quarterly update December 2020. Safety Platform for Emergency Vaccines. Summary: The report updates the list of adverse events of special interest AESI) associated with COVID-19 vaccines, generated by the Safety Platform for Emergency Vaccines (SPEAC) Project. The quarterly review focuses on new
Reference: McGee, S., & De Waal, R. (2020). Rapid review of remdesivir for COVID-19: Update 15 December 2020. South African National Department of Health. Summary: The South African National Department of Health conducted a rapid review of remdesivir’s efficacy for treating hospitalised COVID-19 patients. The analysis included five randomised controlled trials (RCTs) with over 7,700
Reference: U.S. Food and Drug Administration. (2020). Vaccines and related biological products advisory committee meeting December 10, 2020 FDA briefing document Pfizer-BioNTech COVID-19 vaccine. https://www.fda.gov/media/144246/download Summary: On December 10, 2020, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) reviewed Pfizer-BioNTech’s COVID-19 vaccine, BNT162b2, which received an Emergency Use Authorization (EUA) request on November 20,
Reference: Joi, P. (2020). What is the difference between efficacy and effectiveness? Gavi, the Vaccine Alliance. Retrieved from https://www.gavi.org/vaccineswork/what-difference-between-efficacy-and-effectiveness Summary: Efficacy and effectiveness are two crucial terms in vaccine science, often conflated but distinct. Efficacy refers to the performance of a vaccine under ideal, controlled conditions, typically demonstrated in clinical trials where a vaccinated group